Features Screener Stocks Charts
Sign In Sign Up

Suven Life Sciences Limited Cash Flow Statement

NSE:SUVEN | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Free Cash Flow

₹-1.91B

SUVEN's free cash flow was negative at ₹-1.91B in FY 2025, down 65.7% from FY 2024. The company spent more on capital investments than it generated from operations.

2-year SUVEN cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income -1.06B -1.61B
Cash flow Operating Activities -1.15B -1.54B
Investments in PPE 0 -372.76M
Cash flow Investing Activities 944.36M 1.55B
Dividend Paid 0 0
Cash flow Financing Activities -10.54M -7.56M
Cash at beginning of period 370.19M 149.32M
Cash at end of period 149.32M 150.26M
Free Cash Flow -1.15B -1.91B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025